{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreif7spxn7h7jlusty6umd4mtg3sademcrtkclil4fv4lu6lfxnil6i",
    "uri": "at://did:plc:jpckpkvpjawehyqenhblotzo/app.bsky.feed.post/3mlfju37n3qb2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic4hnv34vhhcjkop4qbtbmlfcozd7fcj7c4qxhpzd64ju7dzslnpq"
    },
    "mimeType": "image/jpeg",
    "size": 22136
  },
  "path": "/latest/white-house-set-to-oust-fda-chief-marty-makary-as-successor-identified/",
  "publishedAt": "2026-05-09T04:14:04.000Z",
  "site": "https://humenglish.com",
  "tags": [
    "Latest",
    "World",
    "White House set to oust FDA chief Marty Makary as successor identified",
    "HUM News English"
  ],
  "textContent": "WEB DESK: The White House has moved to terminate the tenure of Marty Makary as Commissioner of the U.S. Food and Drug Administration (FDA), according to sources familiar with the matter.\n\nIn a swift bid to ensure continuity at the federal health regulator, the administration is reportedly preparing to name Kyle Diamantas, the current FDA Deputy Commissioner overseeing the agency’s food group, as the acting head, according to _Reuters._\n\nThe decision marks the latest significant leadership shake-up within the Department of Health and Human Services, reflecting a shift in the administration's strategic direction for public health oversight.\n\n## A sudden departure from the helm\n\nThe move to fire Makary comes after a period of internal deliberation within the White House, with three sources confirming that the plan for his removal has been formally signed off.\n\nWhile the specific catalysts for the dismissal remain under wraps, the departure of a sitting FDA Commissioner often signals a desire for a change in policy pace or a realignment of the agency’s priorities with executive goals.\n\nMakary, a prominent figure in the medical community, has led the agency through a complex period of regulatory scrutiny, but it appears the administration is now looking for a fresh perspective to steer the organisation forward.\n\n### Internal promotion to ensure stability\n\nTo bridge the leadership gap, the White House is expected to turn to Kyle Diamantas, a seasoned official within the FDA’s internal ranks.\n\nCurrently serving as Deputy Commissioner with a specific focus on the agency’s food group, Diamantas is viewed as a \"safe pair of hands\" capable of managing the transition.\n\nHis deep familiarity with the agency’s bureaucratic structure and his recent work on food safety and nutrition policy make him the primary candidate for the acting role.\n\nIf confirmed, his appointment will be tasked with maintaining the momentum of ongoing drug approvals and food safety inspections while a permanent successor is sought.\n\nThe post White House set to oust FDA chief Marty Makary as successor identified appeared first on HUM News English.",
  "title": "White House set to oust FDA chief Marty Makary as successor identified"
}